# Aardvark Therapeutics, Inc.: Form 8-K, filed Feb 14, 2025

- Company: [Aardvark Therapeutics, Inc.](/companies/aard.md) (CIK 1774857)
- Form: 8-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 16:01 ET
- Period: 2025-02-14
- Accession: 0001193125-25-027245
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/d890894d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1774857/000119312525027245/d890894d8k.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-027245. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
